Journal
EPILEPSY RESEARCH
Volume 98, Issue 2-3, Pages 130-134Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.eplepsyres.2011.08.020
Keywords
Levetiracetam; Oral clearance; Elderly and very elderly patients; Pharmacokinetics; Therapeutic drug monitoring
Categories
Ask authors/readers for more resources
We aimed to compare apparent steady-state oral clearance (CL/F) of the antiepileptic drug levetiracetam (LEV) in elderly (66-80 years, n = 105) and very elderly (81-96 years, n = 70) vs nonelderly (30-65 years, n = 97) patients with epilepsy. Median weight-normalized CL/F (mL min(-1) kg(-1)) decreased from 1.23 (nonelderly) to 0.83 (elderly) and 0.59 (very elderly) (p < 0.001). LEV CL/F significantly declines with aging, elderly and very elderly patients requiring an about 30% and 50% lower dose, respectively, compared to nonelderly adults to achieve a given LEV plasma concentration. (C) 2011 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available